P. Ball

发表

Efficacy of Gemifloxacin in Acute Exacerbations of Chronic Bronchitis: a Randomised, Double-Blind Comparison with Trovafloxacin

L. Mandell, R. Wilson, T. Henkel, 2001, Journal of chemotherapy.

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

L. Mandell, G. Tillotson, G. Patou, 2004, International journal of antimicrobial agents.

Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies.

R. Stahlmann, P. Ball, S. Choudhri, 2004, Clinical therapeutics.

Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

P. Ball, 2003, Current therapeutic research, clinical and experimental.

Meeting report: Fourth Forum on Respiratory Tract Infections, Sitges, Spain, 8 11 February 2007.

G. Tillotson, P. Ball, 2007, The Journal of antimicrobial chemotherapy.

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.

P. Ball, 1990, The Journal of antimicrobial chemotherapy.

Treatment of Community-Acquired Respiratory Tract Infections

L. Mandell, P. Ball, 2003 .

Tolerability of Fluoroquinolone Antibiotics

G. Tillotson, P. Ball, 1995, Drug safety.

Adverse drug reactions: implications for the development of fluoroquinolones.

P. Ball, 2003, The Journal of antimicrobial chemotherapy.

Quinolone generations: natural history or natural selection?

P. Ball, 2000, The Journal of antimicrobial chemotherapy.

Acute exacerbations of chronic bronchitis.

P. Ball, 2000, Current opinion in infectious diseases.

Acute Exacerbations of Chronic Bronchitis: In Search of a Definition

P. Ball, 2000 .

Conclusions: the future of antimicrobial therapy - Augmentin and beyond.

P. Ball, 2007, International journal of antimicrobial agents.

Infective pathogenesis and outcomes in chronic bronchitis

P. Ball, 1996, Current opinion in pulmonary medicine.

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.

L. Mandell, T. File, H. Lode, 2002, Clinical therapeutics.

Amoxycillin clavulanate: an assessment after 15 years of clinical application.

G. Rolinson, P. Ball, A. Geddes, 1997, Journal of chemotherapy.

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations

P. Ball, 1995, Chest.

New fluoroquinolones: Real and potential roles

P. Ball, 1999, Current infectious disease reports.

Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections.

T. File, T. Henkel, M. Twynholm, 2001, International journal of antimicrobial agents.

Acute exacerbations of chronic bronchitis: an international comparison.

B. Make, P. Ball, 1998, Chest.

Antimicrobial safety and tolerability: differences and dilemmas.

L. Mandell, G. Tillotson, P. Ball, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.

Jerome J. Schentag, L. Mandell, P. Ball, 2002, Clinical therapeutics.

Future antibiotic trials.

P. Ball, 2000, Seminars in respiratory infections.

Therapeutic advances of new fluoroquinolones.

G. Tillotson, P. Ball, A. Fernald, 1998, Expert opinion on investigational drugs.

Development and characterization of a monoclonal antibody specific for Listeria monocytogenes and Listeria innocua

M. G. Johnson, A. Bhunia, P. Ball, 1991, Infection and immunity.

Safety of the New Fluoroquinolones Compared with Ciprofloxacin

P. Ball, 2000, Journal of chemotherapy.

Overview of experience with ofloxacin in respiratory tract infection.

P. Ball, 1990, Scandinavian journal of infectious diseases. Supplementum.

Long-term use of quinolones and their safety.

P. Ball, Peter Ball, 1989, Reviews of infectious diseases.

A 20–24 H MICROCOLONY‐IMMUNOBLOT TECHNIQUE to DIRECTLY DETECT and ENUMERATE LISTERIA MONOCYTOGENES INOCULATED INTO FOODS

A. Bhunia, Michael G. Johnson, P. Ball, 1992 .

Adverse reactions and interactions of fluoroquinolones.

P. Ball, 1989, Clinical and investigative medicine. Medecine clinique et experimentale.

Bacterial resistance to fluoroquinolones: Lessons to be learned

P. Ball, 1994, Infection.

Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency.

P. Ball, 2000, International journal of clinical practice.

Comparative Tolerability of the Newer Fluoroquinolone Antibacterials

L. Mandell, G. Tillotson, Y. Niki, 1999, Drug safety.

Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

P. Ball, P Ball, 2000, The Journal of antimicrobial chemotherapy.

Therapy for pneumococcal infection at the millennium: doubts and certainties.

P. Ball, Peter Ball, 1999, The American journal of medicine.

New antibiotics for community-acquired lower respiratory tract infections: improved activity at a cost?

P. Ball, 2000, International journal of antimicrobial agents.

The future role and importance of macrolides.

P. Ball, 1991, The Journal of hospital infection.

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.

T. File, O. Cars, F. Baquero, 2002, The Journal of antimicrobial chemotherapy.

Future of the quinolones.

P. Ball, 2001, Seminars in respiratory infections.

The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections.

P. Ball, 2007, International journal of antimicrobial agents.

Fluoroquinolone Safety and Tolerability

P. Ball, 2000 .

Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections

P. Ball, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Ciprofloxacin: an overview of adverse experiences.

P. Ball, P. Ball, 1986, The Journal of antimicrobial chemotherapy.

Acute infective exacerbations of chronic bronchitis.

J. M. Harris, R. Wilson, G. Tillotson, 1995, QJM : monthly journal of the Association of Physicians.